Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploration of the Retinal Deep PhenotypingTM (RDP) Platform for the Identification of Spatial-spectral Features in Different Types of Drusenoid Deposits in Dry Age-related Macular Degeneration (AMD)

NCT06860555 is registered in ClinicalTrials.gov with Optina Diagnostics Inc. as lead sponsor.

NCT NCT06860555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06860555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploration of the Retinal Deep PhenotypingTM (RDP) Platform for the Identification of Spatial-spectral Features in Different Types of Drusenoid Deposits in Dry Age-related Macular Degeneration (AMD)
Lead sponsor
Optina Diagnostics Inc.
Phase
Observational
Overall status
Completed
Start date
November 8, 2022
Completion date
August 15, 2023
Enrollment
112 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry age related macular degeneration